#127

id 127
company_id 317
round_name Growth
announced_date 2026-05-08
closed_date
amount_raised_usd 250000000
pre_money_val_usd
post_money_val_usd
source_form_d_id
source_s1_id
notes Blackstone Life Sciences. Pancreatic insufficiency oral enzyme therapy. $280M+ total. Source: StrictlyVC 2026-05-08
created_at 2026-05-12T12:07:37.334581+00:00
updated_at 2026-05-22T23:25:44.300201+00:00
round_type_id 12
currency_code USD
source_record_id
tenant_id 1